We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Risk of Renal Cell Carcinoma After Hysterectomy: Is It All Obesity?

Simon B. Dimmitt, MBBS, FRACP, FCSANZ
Arch Intern Med. 2011;171(13):1215-1216. doi:10.1001/archinternmed.2011.303.
Text Size: A A A
Published online


Altman and colleagues1 may well have underestimated the contribution of overweight and obesity to the increased incidence of renal cell cancer that they observed after hysterectomy. This is important in the absence of alternative plausible biological explanations for this finding. Obesity was unfortunately not analyzed in their study. They note some evidence for reduced rates of hysterectomy with obesity, presumably related to anticipated increased operative risk. However, overweight and obesity predispose to fibroids,2 uterine prolapse,3 endometrial polyps,3 and of course endometrial carcinoma, common indications for hysterectomy. Obesity has been consistently shown to predispose to renal cell carcinoma4,5 and, indeed, a large range of other neoplasms. However, if excess weight contributed to the increased renal cell carcinoma seen after hysterectomy, it is surprising that Altman and colleagues1 did not also find some evidence for an increase in other malignant neoplasms. That the association between obesity and malignancy appears to be strongest for renal cell carcinoma5 may be the reason why increased renal cell carcinoma stood out in the analysis by Altman and colleagues.1 Further studies may be required to clarify these issues.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





July 11, 2011
Daniel Altman, MD, PhD
Arch Intern Med. 2011;171(13):1215-1216. doi:10.1001/archinternmed.2011.304.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Risk of renal cell carcinoma after hysterectomy: is it all obesity? Arch Intern Med 2011;171(13):1215; author reply 1215-6.

Promoción de la salud en el ciclo de vida